THC methylcarbonate
 | |
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C23H32O4 |
| Molar mass | 372.505 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
THC methylcarbonate (Δ9-THC-methylcarbonate) is a semi-synthetic derivative of tetrahydrocannabinol, first reported as a designer drug in August 2024 when it was identified in a seized shipment by customs in Sweden.[1][2] Coincidentally, it was the 1000th new psychoactive substance identified by the EU Early Warning System on New Psychoactive Substances since it was first established in 1997.[3]
Related THC carbonate and carbamate prodrugs have been patented by Zynerba Pharmaceuticals.[4]
See also
[edit]References
[edit]- ↑ "EU‑EWS‑RCS‑FN‑2024‑0047: Formal Notification of delta‑9‑THC‑methylcarbonate" (PDF). EUDA Action on New Drugs Sector. 2024-12-18. Retrieved 2025-06-12.
- ↑ "EDR 2025: Full Book (6 June 2025 – English version)" (PDF). European Union Drug Report (EUDA). 2025-06-06. Retrieved 2025-06-12.
- ↑ "The EU Early Warning System monitors 1000 NPS". European Union Drugs Agency (EUDA). 2024-12-19. Retrieved 2025-06-12.
- ↑ US 8,227,627 B2, Stinchcomb AL, Golinski MJ, Hammell DC, Howard JL, published 2007‑11‑30, issued 2012‑07‑24, assigned to Alltranz Inc. (original); Zynerba Pharmaceuticals Inc. (current)
 | This cannabinoid related article is a stub. You can help Wikipedia by adding missing information. |